Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis

The pharmaceutical industry has in recent years come under attack from an ethical point of view concerning its patents and the non-accessibility of life-saving drugs for many of the poor both in less developed countries and in the United States. The industry has replied with economic and legal justi...

Full description

Saved in:  
Bibliographic Details
Main Author: George, Richard T. De (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Cambridge Univ. Press 2005
In: Business ethics quarterly
Year: 2005, Volume: 15, Issue: 4, Pages: 549-575
Online Access: Volltext (JSTOR)
Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000caa a22000002 4500
001 1824199996
003 DE-627
005 20230426081009.0
007 cr uuu---uuuuu
008 221202s2005 xx |||||o 00| ||eng c
024 7 |a 10.5840/beq200515444  |2 doi 
035 |a (DE-627)1824199996 
035 |a (DE-599)KXP1824199996 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a George, Richard T. De  |e VerfasserIn  |4 aut 
245 1 0 |a Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis 
264 1 |c 2005 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a The pharmaceutical industry has in recent years come under attack from an ethical point of view concerning its patents and the non-accessibility of life-saving drugs for many of the poor both in less developed countries and in the United States. The industry has replied with economic and legal justifications for its actions. The result has been a communication gap between the industry on the one hand and poor nations and American critics on the other. This paper attempts to present and evaluate the arguments on all sides and suggests a possible way out of the current impasse. It attempts to determine the ethical responsibility of the drug industry in making drugs available to the needy, while at the same time developing the parallel responsibilities of individuals, governments, and NGOs. It concludes with the suggestion that the industry develop an international code for its self-regulation. 
773 0 8 |i Enthalten in  |t Business ethics quarterly  |d Cambridge : Cambridge Univ. Press, 1991  |g 15(2005), 4, Seite 549-575  |w (DE-627)341900230  |w (DE-600)2069764-8  |w (DE-576)273911066  |x 2153-3326  |7 nnns 
773 1 8 |g volume:15  |g year:2005  |g number:4  |g pages:549-575 
856 |3 Volltext  |u http://www.jstor.org/stable/3857978  |x JSTOR 
856 4 0 |u https://doi.org/10.5840/beq200515444  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/business-ethics-quarterly/article/abs/intellectual-property-and-pharmaceutical-drugs-an-ethical-analysis/2C77EB82C5E84CD5DE7DAA08330840C0  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4223018175 
LOK |0 003 DE-627 
LOK |0 004 1824199996 
LOK |0 005 20221202052654 
LOK |0 008 221202||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-11-29#7AA6D1D5EA7962C4C504CFA6BFAA40C55E938CE9 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/3857978 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
ORI |a SA-MARC-ixtheoa001.raw